HK1002019A1 - Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one - Google Patents

Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one

Info

Publication number
HK1002019A1
HK1002019A1 HK98101031A HK98101031A HK1002019A1 HK 1002019 A1 HK1002019 A1 HK 1002019A1 HK 98101031 A HK98101031 A HK 98101031A HK 98101031 A HK98101031 A HK 98101031A HK 1002019 A1 HK1002019 A1 HK 1002019A1
Authority
HK
Hong Kong
Prior art keywords
compound
pregn
hydroxy
methyl
pharmaceutical composition
Prior art date
Application number
HK98101031A
Other languages
English (en)
Inventor
G A J M T Sas
Van E M Doornum
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19854317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1002019(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of HK1002019A1 publication Critical patent/HK1002019A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98101031A 1989-03-18 1998-02-11 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one HK1002019A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8900673 1989-03-18

Publications (1)

Publication Number Publication Date
HK1002019A1 true HK1002019A1 (en) 1998-07-24

Family

ID=19854317

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101031A HK1002019A1 (en) 1989-03-18 1998-02-11 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one

Country Status (17)

Country Link
US (1) US5037817A (ja)
EP (1) EP0389035B1 (ja)
JP (2) JP3139709B2 (ja)
KR (1) KR0183401B1 (ja)
AT (1) ATE98490T1 (ja)
AU (1) AU625083B2 (ja)
CA (1) CA2011452C (ja)
DE (1) DE69005165T2 (ja)
DK (1) DK0389035T3 (ja)
ES (1) ES2062292T3 (ja)
FI (1) FI94865C (ja)
HK (1) HK1002019A1 (ja)
IE (1) IE63051B1 (ja)
MX (1) MX9203787A (ja)
NZ (1) NZ232946A (ja)
PT (1) PT93488B (ja)
ZA (1) ZA901674B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0613687T3 (da) * 1993-03-05 1999-12-06 Akzo Nobel Nv Anvendelse af pregnanderivat til behandling af tumorer
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
TR200101083T2 (tr) * 1998-10-16 2001-08-21 Akzo Nobel N.V. (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
US7045513B1 (en) 1999-03-18 2006-05-16 Genelabs Technologies, Inc. DHEA composition and method
RU2220727C2 (ru) * 1999-03-18 2004-01-10 Дженелабс Текнолоджис, Инк. Композиция, содержащая дегидроэпиандростерон, и способы ее изготовления и применения
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
AU2002347973A1 (en) * 2001-10-18 2003-04-28 Ivax Corporation Novel tibolone formulations
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
RU2004125594A (ru) * 2002-01-22 2005-03-10 Акцо Нобель Н.В. (NL) Применение тиболона при лечение симптомов, связанных с введением лекарств, препятствующих синтезу эндогенного эстрогена
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
CN1324041C (zh) * 2003-04-01 2007-07-04 上海迪赛诺医药科技开发有限公司 替勃龙晶型i的制备方法
PL1499278T3 (pl) * 2003-05-23 2005-09-30 Msd Oss Bv Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon
WO2006125453A1 (en) * 2005-05-23 2006-11-30 Newchem S.P.A. Process for the preparation of pure crystalline tibolone
EP1821571A1 (en) * 2006-02-15 2007-08-22 Oticon A/S Loop antenna for in the ear audio device
ITMI20130120A1 (it) * 2013-01-25 2014-07-26 Ind Chimica Srl Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one
HUE055164T2 (hu) 2016-05-04 2021-11-29 Novalon S A Cukoralkoholok alkalmazása Tobolon tartalmú készítményekben

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (ja) * 1964-06-16
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
US4447426A (en) * 1982-01-18 1984-05-08 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
US5037817A (en) 1991-08-06
ES2062292T3 (es) 1994-12-16
KR0183401B1 (ko) 1999-05-01
DE69005165D1 (de) 1994-01-27
KR900013950A (ko) 1990-10-22
IE63051B1 (en) 1995-03-22
PT93488B (pt) 1996-02-29
IE900709L (en) 1990-09-18
ZA901674B (en) 1990-12-28
DK0389035T3 (da) 1994-02-14
CA2011452A1 (en) 1990-09-18
AU5139490A (en) 1990-09-20
FI901328A0 (fi) 1990-03-16
MX9203787A (es) 1992-07-01
AU625083B2 (en) 1992-07-02
EP0389035A1 (en) 1990-09-26
NZ232946A (en) 1991-08-27
JP2001139473A (ja) 2001-05-22
JPH0347195A (ja) 1991-02-28
ATE98490T1 (de) 1994-01-15
EP0389035B1 (en) 1993-12-15
CA2011452C (en) 1999-05-25
FI94865C (fi) 1995-11-10
FI94865B (fi) 1995-07-31
JP3139709B2 (ja) 2001-03-05
PT93488A (pt) 1990-11-07
DE69005165T2 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
HK1002019A1 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one
IL102616A0 (en) 1,3-oxathiolane nucleoside analogues,methods for the preparation thereof and pharmaceutical compositions containing the same
HU9200302D0 (en) 1,3-oxatiolane-nucleotide analogues
AU6290090A (en) Bi-or trispecific (fab)3 or (fab)4 conjugates
AR244666A1 (es) Procedimiento para preparar compuestos piperidinilicos 1,4-disustituidos, utiles como analgesicos y relajantes musculares.
EP0221728A3 (en) Monosaccharide containing wound healing preparation
AU4717089A (en) N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas
NZ226516A (en) 2,2 dimethylchromene derivatives and pharmaceutical compositions
HUT65702A (en) 1,2-dithiole-3-thione-derivative-based therapeutical compositions
OA09192A (en) "Stabilized sulfur dissolving compositions".
EP0352085A3 (en) Electron microscope
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
IL95210A0 (en) 14,17alpha-etheno-and-ethanoestratrienes,process for the preparation thereof and pharmaceutical compositions containing the same
AU5388090A (en) N-sulfenyl- and n-sulfinyl-n,n'-diacylhydrazides
NZ227235A (en) Substituted 1,5-benzothiazepin-4-one derivatives and pharmaceutical compositions
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
IL101482A0 (en) Substituted 2',3'-dideoxy-5-trifluoromethyluridines,and pharmaceutical compositions containing them
OA09440A (en) "Transformed shigella".
NZ224313A (en) Hetero-ring condensed quinolineamines and pharmaceutical compositions
AU4718989A (en) 4-amino-5-nitro-1,2,3,6-tetrahydropyrimidines
AU1117188A (en) 14,15-substituted lanosterols and their use as hypocholesterolemic agents
AU2403592A (en) 2-aza-2-desamino analogues of 5,8-dideazafolic acid
EP0293633A3 (en) 1,2-di(4-isobutylphenyl)hydrocarbon and its preparation and use as intermediate
NZ224728A (en) 3-acylaminomethyl-5,6,7,8-tetrahyd-pyridine derivatives and pharmaceutical compositions
IL91315A0 (en) 2,3,4,5-tetrahydro-1-benzoxepins,a process for the preparation thereof and pharmaceutical compositions based on these compounds

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100311